SCHEMBL126796

SCHEMBL126796

O=C(O)C(=O)CCO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pyruvate SCHEMBL20641171 0.88 OR51E2 (0.46)
SCHEMBL361798 0.81 OR51E2 (0.79)
SCHEMBL59985 0.80
SCHEMBL801323 0.78 GPR84 (0.57)
SCHEMBL27857415 0.77 OR51E2 (0.73)
SCHEMBL15059014 0.76 GPR84 (0.62)
SCHEMBL8674293 0.76 GPR84 (0.62)
SCHEMBL16295160 0.76 GPR84 (0.62)
SCHEMBL16585474 0.76 HAO1 (0.52)
SCHEMBL9285313 0.76 GPR84 (0.62)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 556 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4743810-A2 CONTACT LENS FORMULATION AND CONTACT LENS CooperVision International Limited (GB) 2026-05-20 EP claimed
EP-4743808-A2 CONTACT LENS FORMULATION AND CONTACT LENS CooperVision International Limited (GB) 2026-05-20 EP claimed
EP-4743807-A1 CONTACT LENS FORMULATION AND CONTACT LENS CooperVision International Limited (GB) 2026-05-20 EP claimed
EP-4743809-A2 CONTACT LENS FORMULATION AND CONTACT LENS CooperVision International Limited (GB) 2026-05-20 EP claimed
US-12611016-B2 Cationic contact lens COOPERVISION INTERNATIONAL LIMITED (GB) 2026-04-28 US claimed
US-12601929-B2 Contact lens COOPERVISION INTERNATIONAL LIMITED (GB) 2026-04-14 US claimed
EP-4680755-A1 METHOD FOR IMPROVING 2, 4 DIHYDROXYBUTYRIC ACID PRODUCTION AND YIELD Adisseo France S.A.S. (FR) 2026-01-21 EP claimed
US-20250340912-A1 METHOD FOR PRODUCING 2,4-DIHYDROXY BUTYRATE OR L-THREONINE USING A MICROBIAL METABOLIC PATHWAY Technische Universität Dresden (DE) 2025-11-06 US claimed
EP-4413404-B1 CATIONIC CONTACT LENS COOPERVISION INT LTD (GB) 2025-10-15 EP claimed
EP-4537135-B1 CONTACT LENS AND PACKAGING SOLUTION COOPERVISION INT LTD (GB) 2025-09-17 EP claimed
US-20060252702-A1 Method of improving cerebral function BLASS JOHN P 2006-11-09 US claimed
US-20060246155-A1 Method of treating impaired mitochondrial function BLASS JOHN P 2006-11-02 US claimed
US-20060189545-A1 Novel chemical entities and methods for their use in treatment of metabolic disorders ACCERA, INC. 2006-08-24 US claimed
EP-1605950-A2 NOVEL CHEMICAL ENTITIES AND METHODS FOR THEIR USE IN TREATMENT OF METABOLIC DISORDERS Accera, Inc. (US) 2005-12-21 EP claimed
WO-2005110429-A1 PHARMACEUTICAL COMPOSITIONS FOR METABOLIC INSUFFICIENCES BLASS JOHN P (US) 2005-11-24 WO claimed
US-20050245612-A1 Pharmaceutical compositions for metabolic insufficiencies BLASS JOHN P 2005-11-03 US claimed
WO-2004077938-A2 NOVEL CHEMICAL ENTITIES AND METHODS FOR THEIR USE IN TREATMENT OF METABOLIC DISORDERS ACCERA INC. (US) 2004-09-16 WO claimed
EP-1032403-A4 NUTRITIONAL SUPPLEMENT FOR CEREBRAL METABOLIC INSUFFICIENCIES BLASS JOHN P (US) 2004-03-31 EP claimed
EP-1032403-A1 NUTRITIONAL SUPPLEMENT FOR CEREBRAL METABOLIC INSUFFICIENCIES CORNELL RESEARCH FOUNDATION, INC. (US) 2000-09-06 EP claimed
WO-1999021565-A1 NUTRITIONAL SUPPLEMENT FOR CEREBRAL METABOLIC INSUFFICIENCIES CORNELL RESEARCH FOUNDATION, INC. (US) 1999-05-06 WO claimed